<?xml version="1.0" encoding="utf-8"?>
<Document>
  <Do_id>24934821</Do_id>
  <Journal>Therapie</Journal>
  <Doc_title>Facial hyperpigmentation during imatinib therapy for gastrointestinal stromal tumor.</Doc_title>
  <Doc_abstract>We report a rare case of facial hyperpigmentation during imatinib therapy for a gastrointestinal stromal tumor. </Doc_abstract>
  <Doc_ChemicalList>Antineoplastic Agents;Benzamides;Piperazines;Protein Kinase Inhibitors;Pyrimidines;Imatinib Mesylate</Doc_ChemicalList>
  <Doc_meshdescriptors>Adult;Antineoplastic Agents;Benzamides;Facial Dermatoses;Female;Gastrointestinal Neoplasms;Gastrointestinal Stromal Tumors;Humans;Hyperpigmentation;Imatinib Mesylate;Piperazines;Protein Kinase Inhibitors;Pyrimidines</Doc_meshdescriptors>
  <Doc_meshqualifiers>administration &amp; dosage;adverse effects;therapeutic use;administration &amp; dosage;adverse effects;therapeutic use;chemically induced;drug therapy;pathology;drug therapy;pathology;chemically induced;administration &amp; dosage;adverse effects;therapeutic use;administration &amp; dosage;adverse effects;therapeutic use;administration &amp; dosage;adverse effects;therapeutic use</Doc_meshqualifiers>
</Document>
